ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Cancer Immunology and Immunotherapy
Immuno-Oncology
Latest ESMO videos
Featured medwireNews
CAR T-Cell Therapy Achieves Relapsed/Refractory Indolent NHL Response
Pembrolizumab Benefit Demonstrated In KEYNOTE-177 Trial
First-Line Pembrolizumab–Axitinib Benefits In Advanced RCC Maintained With Longer Follow-Up
PROs Underpin Frontline Nivolumab–Ipilimumab Benefits For Advanced NSCLC
CheckMate 577 DFS Findings Support Adjuvant Nivolumab
E-Learning
ESMO E-Learning: Immunotherapy Strategies for Colorectal Cancer
ESMO E-Learning: Next Generation Drugs in Kidney Cancer
ESMO E-Learning: New Treatments in Melanoma
ESMO E-Learning: Future Directions in Clinical Research of NSCLC
Factsheets on Biomarkers
Tumour Mutational Load: ESMO Biomarker Factsheet
Meeting resources
ESMO Course
ESMO Virtual Preceptorship on Immuno-Oncology December 2020
Virtual
ESMO Congress
ESMO Immuno-Oncology Virtual Congress 2020
Virtual
ESMO Course
ESMO Virtual Preceptorship on Immuno-Oncology 2020
Virtual
ESMO Congress
ESMO Asia Virtual Congress 2020
Virtual
ESMO Congress